Pre-hospital notification reduced the door-to-needle time for iv t-PA in acute ischaemic stroke

被引:110
作者
Kim, S. K. [1 ]
Lee, S. Y. [1 ]
Bae, H. J. [1 ]
Lee, Y. S. [1 ]
Kim, S. Y. [1 ]
Kang, M. J. [1 ]
Cha, J. K. [1 ]
机构
[1] Dong A Univ Hosp, Stroke Ctr, Pusan 602715, South Korea
关键词
door-to-needle time; pre-hospital notification; stroke; t-PA; TISSUE-PLASMINOGEN ACTIVATOR; IMPLEMENTATION; EXPERIENCE; EFFICACY; SAFETY; DELAYS; TRIAL; ECASS; TPA;
D O I
10.1111/j.1468-1331.2009.02762.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: Intrahospital delay is the most serious obstacle in thrombolysis in acute ischaemic stroke (AIS). We implemented the pre-hospital notification system from the emergency medical information system in our metropolitan area to reduce intrahospital delay. Methods: From October 2007, we implemented a 24-h hotline system between our stroke center and the Korean Emergency Medical Information System in Busan. We compared processing times and clinical outcomes amongst patients after using intravenous tissue type plasminogen activator (iv t-PA) with and without the hotline system. Results: After the pre-hospital notification system was implemented, the rate of iv t-PA use increased from 6.5% to 14.3%. Time of onset in patients with pre-hospital notification was much longer than in patients without (121.5 +/- 34.8 min vs. 74.7 +/- 38.5 min, P < 0.01) notification but door-to-needle time was significantly reduced (28.9 +/- 11.4 min vs. 47.7 +/- 22.8 min, P < 0.01). However, there were no significant differences in 90-day clinical outcomes between the two groups. Conclusions: The pre-hospital notification system reduced intrahospital processing times which led to increased iv t-PA use after AIS. However, the improvement of clinical outcomes in thrombolysis might require organization of not only intrahospital processes but of outside processes such as the early recognition and rapid dispatch of patients with suspected AIS.
引用
收藏
页码:1331 / 1335
页数:5
相关论文
共 20 条
  • [1] Guidelines for the early management of adults with ischemic stroke - A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups
    Adams, Harold P., Jr.
    del Zoppo, Gregory
    Alberts, Mark J.
    Bhatt, Deepak L.
    Brass, Lawrence
    Furlan, Anthony
    Grubb, Robert L.
    Higashida, Randall T.
    Jauch, Edward C.
    Kidwell, Chelsea
    Lyden, Patrick D.
    Morgenstern, Lewis B.
    Qureshi, Adnan I.
    Rosenwasser, Robert H.
    Scott, Phillip A.
    Wijdicks, Eelco F. M.
    [J]. STROKE, 2007, 38 (05) : 1655 - 1711
  • [2] TIME OF HOSPITAL PRESENTATION IN PATIENTS WITH ACUTE STROKE
    BARSAN, WG
    BROTT, TG
    BRODERICK, JP
    HALEY, EC
    LEVY, DE
    MARLER, JR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (22) : 2558 - 2561
  • [3] BREVIS R, 2005, CEREBROVASC DIS, V19, P96
  • [4] Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA Stroke Trial
    Broderick, JP
    Lu, M
    Kothari, R
    Levine, SR
    Lyden, PD
    Haley, EC
    Brott, TG
    Grotta, J
    Tilley, BC
    Marler, JR
    Frankel, M
    [J]. STROKE, 2000, 31 (10) : 2335 - 2341
  • [5] Castillo J, 1996, Rev Neurol, V24, P427
  • [6] Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice
    Chiu, D
    Krieger, D
    Villar-Cordova, C
    Kasner, SE
    Morgenstern, B
    Bratina, PL
    Yatsu, FM
    Grotta, JC
    [J]. STROKE, 1998, 29 (01) : 303 - 303
  • [7] DELAY IN NEUROLOGICAL ATTENTION AND STROKE OUTCOME
    DAVALOS, A
    CASTILLO, J
    MARTINEZVILA, E
    [J]. STROKE, 1995, 26 (12) : 2233 - 2237
  • [8] Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
    Hacke, W
    Kaste, M
    Fieschi, C
    von Kummer, R
    Davalos, A
    Meier, D
    Larrue, V
    Bluhmki, E
    Davis, S
    Donnan, G
    Schneider, D
    Diez-Tejedor, E
    Trouillas, P
    [J]. LANCET, 1998, 352 (9136) : 1245 - 1251
  • [9] HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
  • [10] Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience
    Katzan, IL
    Furlan, AJ
    Lloyd, LE
    Frank, JI
    Harper, DL
    Hinchey, JA
    Hammel, JP
    Qu, A
    Sila, CA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1151 - 1158